Professional Documents
Culture Documents
Kidney Transplantation
Kidney Transplantation
Introduction
• Kidney transplantation has become the
treatment of choice for most patients with
ESRD.
• During the past 40 years, more than 380,000
kidney transplantations have been performed
worldwide
Definition
• Kidney transplantation involves transplanting
a kidney from a living donor or human cadaver
to a recipient who has ESRD
• A nephrectomy of the patient’s own native
kidneys may be performed before
transplantation.
• The transplanted kidney is placed in the
patient’s iliac fossa anterior to the iliac crest.
• The ureter of the newly transplanted kidney is
transplanted into the bladder or anastomosed
to the ureter of the recipient
PREOPERATIVE MANAGEMENT
• Preoperative management goals include
bringing the patient’s metabolic state to a
level as close to normal as possible, making
sure that the patient is free of infection, and
preparing the patient for surgery and the
postoperative course.
• A complete physical examination is performed to
detect and treat any conditions that could cause
complications after transplantation.
• Tissue typing, blood typing, and antibody screening
are performed to determine compatibility of the
tissues and cells of the donor and recipient.
• Other diagnostic tests must be completed to
identify conditions requiring treatment before
transplantation.
• The patient must be free of infection at the
time of renal transplantation because after
surgery the patient will receive medications to
prevent transplant rejection.
• A psychosocial evaluation is conducted to
assess the patient’s ability to adjust to the
transplant, coping styles, social history,social
support available, and financial resources.
• Patient teaching addresses postoperative
pulmonary hygiene, pain management
options, dietary restrictions, intravenous and
arterial lines, tubes (indwelling catheter and
possibly a nasogastric tube), and early
ambulation.
POSTOPERATIVE MANAGEMENT
• The goal of care is to maintain homeostasis until the
transplanted kidney is functioning well.
• Immunosuppressive Therapy
– The survival of a transplanted kidney depends on the
ability to block the body’s immune response to the
transplanted kidney.
– To overcome or minimize the body’s defense mechanism
immunosuppressant agents such as azathioprine (Imuran),
corticosteroids (prednisone) cyclosporine, and OKT-3 (a
monoclonal antibody) are administered (Shapiro, 2000b).
• Doses of immunosuppressant agents are
gradually reduced (tapered) over a period of
several weeks, depending on the patient’s
immunologic response to the transplant.
• ASSESSING THE PATIENT FOR TRANSPLANT
REJECTION
– After kidney transplantation, the nurse assesses
the patient for signs and symptoms of transplant
rejection: oliguria, edema, fever, increasing blood
pressure, weight gain, and swelling or tenderness
over the transplanted kidney or graft.
• Patients receiving cyclosporine may not
exhibit the usual signs and symptoms of acute
rejection. In these patients, the only sign may
be an asymptomatic rise in the serum
creatinine level (more than a 20% rise is
considered acute rejection).
• The results of blood chemistry tests (BUN and
creatinine) and leukocyte and platelet counts
are monitored closely because
immunosuppression depresses the formation
of leukocytes and platelets.
PREVENTING INFECTION